2025
Impact of age on financial toxicity among breast cancer patients with resectable invasive breast cancer: A systematic review.
Myers S, Morton C, Bain P, Obeng-Gyasi S, Paskett E, McAlearney A, Greenup R, Minami C, Mittendorf E, King T. Impact of age on financial toxicity among breast cancer patients with resectable invasive breast cancer: A systematic review. Journal Of Clinical Oncology 2025, 43 DOI: 10.1200/jco.2025.43.16_suppl.e23194.Peer-Reviewed Original ResearchCancer-related costsFinancial toxicitySystematic reviewInvasive breast cancerSocial determinants of healthBreast cancerSymptoms of breast cancerBlood Institute assessment toolIncidence of breast cancerOutcome metricsPatient-reported outcome metricsStage I-III breast cancerDeterminants of healthI-III breast cancerNon-metastatic invasive breast cancerAffordability of careBreast cancer diagnosisYounger ageYoung adultsInstitute assessment toolEnglish-language articlesHealth disparitiesSocial determinantsTreatment-related expensesWeb of Science
2024
Perceptions of Delayed Alopecia Among Breast Cancer Survivors
Premji S, Ruddy K, Vierkant R, Larson N, Loprinzi C, Dulmage B, Lustberg M, Couch F, Olson J, Cathcart-Rake E. Perceptions of Delayed Alopecia Among Breast Cancer Survivors. Clinical Breast Cancer 2024, 25: e170-e177. PMID: 39592290, PMCID: PMC11769767, DOI: 10.1016/j.clbc.2024.09.008.Peer-Reviewed Original ResearchBreast cancer survivorsMayo Clinic Breast Disease RegistryCancer survivorsChemotherapy recipientsStage I-III breast cancerI-III breast cancerBreast cancer diagnosisPersistent bothersome symptomsRespondents' median ageBreast cancer treatmentMental healthDistressing symptomsDisease RegistryCancer diagnosisCohort studyHair lossSurvivorsBreast cancerBothersome symptomsBreastRespondentsSurvey 6 yearsParticipantsBotherCancer treatmentIntegrating the symptom experience and coping in patients with stage I-III breast cancer in China: A qualitative study
Liang M, Xiong Y, Zhu S, Wang Y, Knobf M, Ye Z. Integrating the symptom experience and coping in patients with stage I-III breast cancer in China: A qualitative study. European Journal Of Oncology Nursing 2024, 73: 102692. PMID: 39406178, DOI: 10.1016/j.ejon.2024.102692.Peer-Reviewed Original ResearchStage I-III breast cancerI-III breast cancerSymptom experienceBreast cancerPurposive sample of womenSemi-structured interview guideFramework analysis methodSample of womenTranscribed verbatimQualitative descriptive approachBreast cancer treatmentInterview guidePsychological symptomsEarly survivorshipQualitative studyAudio-recordedMultiple symptomsPurposive samplingDescriptive approachAverage ageThemesWomenPersonal interviewsBreastSymptomsBarriers to and facilitators of improving physical activity and nutrition behaviors during chemotherapy for breast cancer: a sequential mixed methods study
Puklin L, Irwin M, Sanft T, Ferrucci L, Harrigan M, McGowan C, Cartmel B, Zupa M, Winer E, Deyling M, Ligibel J, Basen-Engquist K, Spiegelman D, Sharifi M. Barriers to and facilitators of improving physical activity and nutrition behaviors during chemotherapy for breast cancer: a sequential mixed methods study. Supportive Care In Cancer 2024, 32: 590. PMID: 39141176, DOI: 10.1007/s00520-024-08789-5.Peer-Reviewed Original ResearchConceptsPhysical activityLifestyle interventionSelf-reported PA questionnaireSelf-reported diet qualityBreast cancerHealthy Eating Index-2015Stage I-III breast cancerBenefits of PASequential mixed methods studyI-III breast cancerChemotherapy-related symptomsMixed methods studyThematic content analysisBehavioral goalsSense of controlBody mass indexPA questionnaireSemi-structured interviewsMean body mass indexTranscribed verbatimIntervention armTailored educationDiet qualityNutritional behaviorMental benefitsImpact of semaglutide and tirzepatide administration on weight in women with stage I-III breast cancer.
Fischbach N, Zhou B, Deng Y, Parsons K, Shelton A, Lustberg M. Impact of semaglutide and tirzepatide administration on weight in women with stage I-III breast cancer. Journal Of Clinical Oncology 2024, 42: e24140-e24140. DOI: 10.1200/jco.2024.42.16_suppl.e24140.Peer-Reviewed Original ResearchStage I-III breast cancerI-III breast cancerAdverse breast cancer outcomesBreast cancerMaximal weight lossMean weight lossBreast cancer survivorsDistant breast cancer recurrenceGLP-1 agonistsBreast cancer outcomesStage distributionClinically meaningful weight lossBreast cancer recurrenceWeight loss maintenanceUntreated patientsCancer survivorsMeasures regression analysisIncidence of diabetesWeight lossTreated patientsRetrospective analysisHealth NetworkMental healthCancer outcomesGLP-1Relationship between receipt of combined axillary dissection and nodal irradiation and age.
Myers S, Partridge A, Warren L, Greenup R, Mittendorf E, King T, Kantor O. Relationship between receipt of combined axillary dissection and nodal irradiation and age. Journal Of Clinical Oncology 2024, 42: 11043-11043. DOI: 10.1200/jco.2024.42.16_suppl.11043.Peer-Reviewed Original ResearchBreast cancer-related lymphedemaStage I-III breast cancerI-III breast cancerClinical factorsCancer-related lymphedemaProportion of high school graduatesLower household incomeRisk factorsImpact quality of lifeQuality of lifeNational Cancer DatabaseAssociation of ageSociodemographic factorsLonger life expectancyHispanic ethnicityLow-incomeMedicare patientsNodal irradiationHousehold incomeSociodemographicsImpact qualityCohort characteristicsLife expectancyHigh school graduatesAsian race
2023
Race, geography, and risk of breast cancer treatment delays: A population‐based study 2004–2015
Reeder‐Hayes K, Jackson B, Baggett C, Kuo T, Gaddy J, LeBlanc M, Bell E, Green L, Wheeler S. Race, geography, and risk of breast cancer treatment delays: A population‐based study 2004–2015. Cancer 2023, 129: 925-933. PMID: 36683417, PMCID: PMC11578059, DOI: 10.1002/cncr.34573.Peer-Reviewed Original ResearchConceptsBreast cancer treatment delaysTreatment delayMagnitude of racial disparitiesNon-black patientsStage I-III breast cancerI-III breast cancerPoor-quality carePopulation health resourcesRisk of treatment delayBlack patientsBreast cancer survivalCancer treatment delayPopulation-based studyDiagnosis to first treatmentAssociated with riskBreast cancerCancer RegistryObservational cohort of patientsTreatment delay >Health resourcesPopulation-basedPoisson regressionCancer survivalSociodemographic dataRacial disparities
2021
Racial differences in impact of geography on breast cancer treatment delay.
Reeder-Hayes K, Baggett C, Jackson B, Kuo T, Gaddy J, Bell E, Green L, Wheeler S. Racial differences in impact of geography on breast cancer treatment delay. Journal Of Clinical Oncology 2021, 39: 81-81. DOI: 10.1200/jco.2020.39.28_suppl.81.Peer-Reviewed Original ResearchArea Health Education CenterBlack patientsRacial disparitiesBreast cancer treatment delaysLocal health system characteristicsBlack breast cancer patientsLikelihood of treatment delaysBlack womenTreatment delayNon-black patientsStage I-III breast cancerRisk ratioHealth system factorsPoor quality careCancer registry dataI-III breast cancerPopulation health resourcesHealth Education CenterPatients receive careBlack patients receive careRisk of treatment delayPatient-level factorsModified Poisson regressionCancer treatment delaySignificant racial disparities
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply